The organophosphates are of two classes: those which are toxic directly, and those which require 'activation' in the animal body to produce the actual toxic compound. The directly acting compounds include the phosphates and phosphorothiolates, most of which contain the -P(O)(OR)2 grouping, where R is an alkyl group. The other class includes the phosphorothionates, most of which contain the -P(S)(OR)2 grouping, and the phosphorodiamidates that contain the -P(O)(NR2) grouping.
'Activation' is an oxidative reaction, involving the conversion in phosphorothionates of P(S) into P(O) (Gage, 1953) or, in phosphorodiamidates, of an alkyl into a hydroxyalkyl group (Heath, Lane & Park, 1955; Spencer, O'Brien & White, 1957) . 'Activation' is accomplished in mammals almost exclusively by liver microsomes (Davison, 1955) , and in insects principally by gut and fat body (Metcalf & March, 1953; O'Brien & Spencer, 1953) .
It has been shown that, in mammalian-liver preparations, SKF 525A (2-diethylaminoethyl 2:2-diphenylvalerate hydrochloride) blocks the 'activation' of schradan (octamethylpyrophosphoramide; tetramethylphosphorodiamidic anhydride), Guthion [OO-dimethyl S-(4-oxo-3H-1:2:3-benzotriazine-3-methyl) phosphorodithioate] and parathion (diethyl p-nitrophenyl phosphorothionate) (Davison, 1955; Murphy & DuBois, 1957) . In vivo, SKF 525A is a potent antagonist of poisoning by schradan and Guthion, but not of poisoning by parathion (O'Brien & Davison, 1958) . The present paper examines this paradox further.
The effects of SKF 525A on the toxicity or metabolism of organophosphates in insects have not been reported previously. They are of interest because of the possibility that SKF 525A might be useful as an adjuvant in the treatment of livestock by systemic organophosphates for internal parasites. They may also help to elucidate the nature of the differences between the activating systems of mammals and insects.
METHODS
The mice were female albinos (20-35 g.) from Rolfsmeyer Farms (Madison, Wis.) . The houseflies (Mu8ca domestica) were 1-day-old adult females of a normal CSMA strain. The cockroaches (Periplaneta americana) were adult females, about 28 days moulted.
The organophosphates used were: (1) Chlorthion (dimethyl m-chloro-p-nitrophenyl phosphorothionate; (2) Co-ral (diethyl 3-chloro-4-methylcoumarin-7-yl phosphorothionate); (3) Delnav [mixed isomers of 2:3-p-dioxandithiol SS-bis-(OO-diethyl phosphorodithioate)l; (4) Diazinon (diethyl 6-methyl-2-isopropylpyrimidin-4-yl phosphorothionate); (5) We are indebted to Chemagro Corp. for (1), (2) and (14), Hercules Powder Co. for (3), Geigy Chemical Co. for (4), Fison's Pest Control Ltd. for (5), American Cyanamid Co. for (6) and (11), Dow Chemical Co. for (7) and (12), E. I. du Pont de Nemours Co. for (8), Dr G. Schrader for (10), Monsanto Chemical Co. for (13), which was further purified by Dr E. Y. Spencer according to Casida, Allen & Stahmann (1954) , Dr J. R. Robinson for (15), and Chipman Chemical Co. for (16). Compound (8) was purchased from L. Light and Co. The SKF 525A was presented by Smith, Kline and French Ltd. Lilly 18947 (2:4-dichloro-6-phenylphenoxyethyldiethylamine) was kindly given by Dr H. H. Moorefield. For the synthesis of radioactive parathion, 15 mc of H332PO4 in HCI was placed in a 16 mm. x 100 mm. Carius tube and the water and HCI were removed by a current of dry N2. Then 355 mg. of PSCl3 was added and the tube was sealed and heated 18 hr. at 4000 in a muffle furnace (Vigne & Tabau, 1958) . Subsequent synthesis of parathion was according to Krueger, O'Brien & Dauterman (1960) . The yield was 71% based on PSCI3, the activity 5700 counts/min. per ug./ml., in a liquid-counting Geiger tube.
Paraoxon (diethyl p-nitrophenyl phosphate) was prepared by passing N204 for 5 min. at room temperature through a solution in 10 ml. of methylene chloride of a second batch of 32P-parathion prepared as above. The solvent was removed, the mixture taken up in benzene and the solution added to an alumina column (Woelm, acid, activity grade II). The excess of parathion (239 mg.) was washed through with 200 ml. of benzene, and the paraoxon then eluted off with chloroform. The yield was 20 %, based on the original PSCI3.
Toxicity determinations. The dose of SKF 525A used was the highest which, when injected alone, produced no symptoms. For mice, the SKF 525A (0-2% in 0 9 % NaCl) was injected intraperitoneally at a dose of 20 mg./kg. Immediately after, the organophosphate in 0-2 ml. of propylene glycol/20 g. mouse was injected intraperitoneally. Mortalities were determined 24 hr. thereafter. For houseflies, the SKF 525A in 0 9% NaCl (1 3,u1./fly) was injected into the thoracic muscle, at 100 mg./kg. The organophosphates were dissolved in acetone and applied topically at 1-3 ul./fly to the thorax, immediately after the SKF 525A. With cockroaches, the SKF 525A in 0-9 % NaCl (5 pl./g. wt.) was injected intra-abdominally at 300 mg./kg. The organophosphate, dissolved in the same volume of propylene glycol or ethanol-propylene glycol (1:9, v/v), was then injected intra-abdominally. Parathion metabolism. Each mouse was injected intraperitoneally with [32P]parathion (0-1% in propylene glycol) at a dose of 5 mg./kg., by using an Agla micrometer syringe. At the required time thereafter, the mouse was homogenized with 250 ml. of 5% trichloroacetic acid in a Waring Blendor for 2 min., then filtered through a wire screen. Three such preparations were pooled and counted, then 500 ml. was extracted with 100 ml. of benzene. The phases were separated by centrifuging and the benzene was dried with sodium sulphate and counted; 50 ml. of the benzene solution was passed through a 15 cm. x 1 cm. column of Woelm alumina grade II, and eluted with a further 50 ml. of benzene. Another 10 ml. of benzene was then passed through to check for complete elution, then 50 ml. of chloroform was passed through. The benzene fraction contained the parathion, and the chloroform contained the paraoxon (Plapp & Casida, 1958 paraoxon was added directly to the homogenate before filtering, subsequent recovery into the chloroform was complete (103%). Schradan activation. One gut from a female cockroach was incubated in a 10 ml. beaker with 1-5 ml. of 0-05M-2-amino-2-hydroxymethylpropane-1:3-diol (tris) buffer, pH 7.4, 0'25 ml. of 0.5 % schradan and 0-25 ml. of water or SKF 525A solution. The beakers were shaken on the platform of a wrist-action shaker for 90 min. The solutions from four were pooled and duplicate 1 ml. samples added to a Warburg flask containing 1 ml. of a cholinesterase preparation (laked human erythrocytes at one-third their blood concentrations) and 0.5 ml. of 1.5 % NaHCO3. The standard Warburg assay was used at 25°, with 0-2 ml. of 2% acetylcholine bromide as substrate.
RESULTS
Studies on mammals and their tissues Toxicity. Table 1 shows that in mice the only phosphorothionate against which SKF 525A provided substantial protection was dimethoate.
Further work showed that the LD50 of dimethoate was raised from 80 to 195 mg./kg. by the SKF 525A. This 2*4-fold increase is comparable with the 16-2-0-fold increase previously reported for Guthion (O'Brien & Davison, 1958 Davison, 1958) had shown the SKF 525A did not protect mice from parathion poisoning. A brief study showed that neither did it synergize para-thion poisoning, e.g. 10 mg. of parathion/kg. killed 10 % of control mice or of mice treated with 20 mg.
of SKF 525A/kg. (duplicate batches each of ten mice were used).
In a brief study on rats, involving 28 animals, little or no protective action against dimethoate was found, e.g. 350 mg. of dimethoate/kg. killed 89 % without or 78 % with SKF 525A.
Protection against all three phosphorodiamidic compounds was given by SKF 525A in mice. Further studies with mipafox indicated about a 1-6-fold increase in the LDw0; this may be compared with the fourfold increase reported for schradan (O'Brien & Davison, 1958) . Table 1 indicates that for dimefox the increase in LD50 must be substantially less than twofold.
The compound Lilly 18947 is an inhibitor of barbiturate degradation (Fouts & Brodie, 1956 ). Since it has been shown that such compounds antagonize schradan poisoning (O'Brien & Davison, 1958 ), Lilly 18947 was tested in the mouse in the same way as SKF 525A, by using the hydrobromide salt. It was an effective antagonist; 60 mg./kg. protected fully against the standard 25 mg./kg. dose of schradan which alone gave 67 % mortality.
However, it was less effective than SKF 525A, weight for weight: at 20 mg. of antagonist/kg. the standard schradan dose gave 31 % mortality with Lilly 18947, compared with 0 % for SKF 525A.
With phosphates and phosphorothiolates, no activation is required; consequently if SKF 525A acts solely by blocking activation, it should have no effect in these cases. This was confirmed with TEPP and paraoxon (Table 1) . Tetram was studied because of the report of Scaife & Campbell (1959) that the degradation of this compound was accomplished by liver microsomes and was inhibited in vitro by SKF 525A. If this was also true in vivo, SKF 525A should synergize Tetram poisoning. This was confirmed (Table 1) . Further examinations showed that 20 mg. of SKF 525A/kg. lowered the normal LD50 of Tetram (0.55 mg./ kg.) to 020 mg./kg.
Metaboli8m. The essential paradox to resolve was: why does SKF 525A antagonize parathion 'activation' by liver homogenates, yet have no saving effect on parathion poisoning? The first point examined was the effect of SKF 525A on [32P]parathion metabolism in the intact mouse. Fig. 1 shows that the production of paraoxon (the actual toxic compound) was substantially increased by SKF 525A in vivo, in contrast with the results expected from the report on liver homogenates (Davison, 1955) . There was negligible effect on the levels of parathion or degradation products.
A study was then made of the production by liver slices of paraoxon from parathion. Table 2 shows that paraoxon production was substantially inhibited by mM-SKF 525A, the concentration used by Davison. However, Gaudette & Brodie (1959) found that high concentrations (5 mM) of SKF 525A caused non-specific inhibition of microsomal reactions, owing to protein denaturation; at 0 4 mm, this non-specific effect disappeared. The Fig. 1 . Results are corrected for partial recovery.
liver-slice work was therefore repeated with 0-4 mM-SKF 525A; as Table 2 shows, inhibition of paraoxon production was still found. Davison's results are therefore confirmed; but the results in vivo and in vitro are in conflict.
The only explanation that would resolve the conflict would be that paraoxon degradation in vivo was inhibited by SKF 525A. This rather improbable hypothesis was examined by injecting
[P2P]paraoxon into mice and studying its degradation. As Fig. 2 shows, paraoxon degradation was indeed inhibited by 20 mg. of SKF 525A/kg.
Studies on insects and their tissues Toxicity. As schradan is not toxic to the cockroach and housefly, it could not be tested in this study.
Against the cockroach, only Guthion, paraoxon, parathion and ronnel were tested. A clear-cut synergism, instead of the expected protection, was found with Guthion: the LD50 was lowered by SKF 525A treatment from 2-5 to 0-5 mg./kg. The plots of probit-of-mortality against organophosphate dose were not parallel for the two treatments (i.e. with and without SKF 525A), so that the LD85 was slightly increased by the SKF 525A, from 5-0 to 5-5 mg./kg. The toxicity of parathion was unaffected: the LD50 at 1 week was 0-9 mg./ kg. with or without SKF 525A. However, the agent delayed the toxic effects; after one day, 1 mg. of parathion/kg. killed or prostrated an average of 80 %, but with SKF 525A this figure was reduced to 10 %. The toxicity of paraoxon was synergized: thus 0-5 mg. of paraoxon/kg. killed an average of 20 %, but with SKF 525A this figure was increased to 80%. With ronnel, slight synergism was found: the LD50 was 59 mg./kg. without and 51 mg./kg. with SKF 525A.
The results with the fly are shown in Table 3 . For Guthion and Diazinon distinct synergism was found; in the other four cases there was little effect.
Metabolism. The oxidation of [32P]parathion to paraoxon was studied in the living cockroach. As  Fig. 3 shows, although SKF 525A inhibited paraoxon formation to a small extent during the first 30 min., yet by 1 hr. it had almost doubled the paraoxon level. This second phase of the effect resembles that found in the mouse (Fig. 1) .
Paraoxon production from cockroach gut in vitro was next studied, with the two SKF 525A concentrations which had been used for mouse liver. As Table 2 shows, SKF 525A substantially inhibited paraoxon production, to an extent remarkably similar to that found for liver.
Finally the degradation of injected [32P]paraoxon was examined. Fig. 4 shows that paraoxon was degraded less rapidly in the cockroach than in the mouse, and that the degradation was inhibited by 20 mg. of SKF 525A/kg. As in the mouse, this finding accounts for the fact that SKF 525A causes increased concentrations of paraoxon after injection of parathion, in spite of its inhibitory effect on paraoxon synthesis.
In order to study the effects of SKF 525A upon 'activation' of schradan by cockroach guts, schradan was incubated with the guts and samples were taken after (usually) 60 min. for anticholin- Table 3 . Effect of SKF 525A on the toxicity of pho8phoro-thionate8 and -dithoate8 to houseflies
The procedure was as in esterase assay of the 'activation' product. Fig. 5 shows for schradan that activation was roughly linear for 1-75 hr., and also demonstrates the considerable variation with individual guts. From the limited data available, SKF 525A appears to be an inhibitor of 'activation' of phosphorothionates in general. Yet it sometimes antagonizes, sometimes synergizes and sometimes has no effect upon phosphorothionate poisoning, according to the species and the phosphorothionate that are examined. Presumably this variation reflects variations in the relative potency of its inhibition of activation and degradation in each case. The only non-metallic inhibitor of a paraoxondegrading enzyme reported so far is ethylenediaminetetra-acetic acid (Main, 1960 The activating systems of the cockroach and mouse are virtually identical in their sensitivity to SKF 525A (Table 3 ). The demonstration that the 'activation' of schradan by cockroach gut is inhibited by SKF 525A, as had been shown for 'activation' by mouse liver (Davison, 1955) , is a further point of similarity. Nevertheless, there is evidence that the systems are in fact substantially different, particularly in their cofactor requirements when broken-cell preparations are used (O'Brien, 1956) .
One feature of this study is the lack of correlation between toxicity and the total body level of paraoxon. For instance, Figs. 1 and 2 show that the agent SKF 525A has a marked effect upon the paraoxon level of mice poisoned either with parathion or paraoxon. Yet the agent has a negligible effect on the toxicity of these organophosphates. This finding throws some doubt on the validity of conclusions about toxicity drawn from observations on whole-body levels of toxic compound, as was extensively done by Krueger et al. (1960) , and as is implicit in the present study. Instead one should perhaps study the concentration of toxic compound in, say, the nervous system. Compounds of this type are particularly likely to diffuse rapidly into lipoidal tissue, such as the nervous system, by virtue of their high lipidwater partition coefficients. We have observed partition coefficients between triacetin and water of 6900 for parathion, 37 for paraoxon and 39 for malathion. SUMMARY 1. SKF 525A (2-diethylaminoethyl 2:2-diphenylvalerate hydrochloride) protects mice against poisoning by the three phosphorodiamidic compounds tested. Of the eight phosphorothionates tested, protection against dimethoate only was observed.
2. With houseflies and American cockroaches, SKF 525A gave no protection against any phosphorothionates.
3. SKF 525A inhibited the conversion of parathion into paraoxon by mouse-liver slices or cockroach guts.
4. SKF 525A inhibited the 'activation' of schradan by cockroach guts, as had previously been shown for rat-liver preparations.
5. With mice and cockroaches in vivo, SKF 525A increased the concentration of paraoxon caused by the injection of parathion, and reduced the degradation of injected paraoxon.
6. It was concluded that the diverse effects of SKF 525A on organophosphate toxicity in various species were due to the variations in the importance of inhibition of 'activating' as opposed to degrading enzymes.
